Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " June 24, 2009":" July 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
Condition: HIV Infection
Interventions: Drug: FTC/TDF;   Drug: Placebo
2 Completed Effect of Antacids on the Pharmacokinetics of Raltegravir
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: antacid
3 Unknown  Simplification From Protease Inhibitors to Raltegravir
Condition: HIV Infections
Intervention: Drug: Raltegravir (Use RAL as a simplification strategy)
4 Completed IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients
Condition: HIV Infections
Interventions: Drug: Isentress®;   Drug: Celsentri®
5 Completed Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya
Condition: HIV Infections
Intervention: Procedure: Integrated ANC, PMTCT, HIV services
6 Active, not recruiting Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
Conditions: Pediatric HIV;   HIV Infections
Intervention: Drug: Boosted Atazanavir
7 Completed Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: efavirenz/emtricitabin/tenofovir;   Drug: lopinavir/ritonavir
8 Completed
Has Results
A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 2N(t)RTI;   Drug: Ritonavir-boosted lopinavir
9 Completed HIV Viral Load Monitoring in Resource-Poor Settings
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: HIV-1 viral load testing
10 Completed Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)
Conditions: Pulmonary Complications;   HIV Infections
Intervention: Other: Smoking Cessation
11 Unknown  Preparing for Adolescent HIV Vaccine Trials in South Africa:
Conditions: HIV Infection;   HIV Infections
Intervention:
12 Completed Integration of Family Planning and HIV Services in Tanzania
Conditions: HIV Infection;   HIV Infections
Intervention: Behavioral: Facilitated Referral
13 Completed Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Behavioral: Tailored Information Program for Safer Sex
14 Approved for marketing An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
15 Terminated Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
Conditions: HIV1 Infection;   HIV Infections
Intervention:
16 Completed Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Conditions: Cervical Cancer Screening;   HIV Infections
Intervention:
17 Active, not recruiting Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
Conditions: HIV Infection;   Pulmonary TB
Intervention: Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
18 Completed Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: maraviroc
19 Completed Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: raltegravir QD;   Drug: atazanavir;   Drug: lamivudine (or emtricitabine)
20 Completed
Has Results
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
Condition: HIV
Interventions: Drug: atazanavir/raltegravir;   Drug: atazanavir/tenofovir/emtricitabine

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.